Vascular Cell Blog
CONFERENCE: Angiogenesis: Advances in Basic Science and Therapeutic Applications
Sponsored by Bayer USA Foundation and Genentech, Inc.
Organizers: Napoleone Ferrara, Anne C. Eichmann and Kenneth Walsh
January 16 - 21, 2012 • Snowbird Resort • Snowbird, Utah
If you would like to submit an abstract please contact our office at abstracts@keystonesymposia.org
or 1-970-262-1230/1-800-253-0685.
There is a $50 late fee for any abstract processed after the abstract deadline.
Posted by Mark Slevin at 08:59 Comments (0)
Perspectives and opportunities for nanomedicine in the management of atherosclerosis.
Perspectives and opportunities for nanomedicine in the management of atherosclerosis.
Source
1] Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, BOX 1234, New York 10029, USA. [2] Department of Vascular Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Abstract
The use of nanotechnology for medical purposes - nanomedicine - has grown exponentially over the past few decades. This is exemplified by the US Food and Drug Administration's approval of several nanotherapies for various conditions, as well as the funding of nanomedical programmes worldwide. Although originally the domain of anticancer therapy, recent advances have illustrated the considerable potential of nanomedicine in the diagnosis and treatment of atherosclerosis. This Review elaborates on nanoparticle-targeting concepts in atherosclerotic disease, provides an overview of the use of nanomedicine in atherosclerosis, and discusses potential future applications and clinical benefits.
- PMID:
- 22015921
- [PubMed - in process]
Posted by Mark Slevin at 08:57 Comments (0)